Brief: Medistim Q2 EBIT Rises To NOK 42.7 Million

Medistim ASA

13/08/2021 06:57

Aug 13 (Reuters) - Medistim ASA  MEDS.OL :
    * SECOND QUARTER AND FIRST HALF FINANCIALS 2021 FOR MEDISTIM
ASA
    * TOTAL REVENUES FOR QUARTER ENDED AT MNOK 109.8 (MNOK 82.5)
AND
INCLUDES MNOK 5.3 GRANTED BY U.S. PAYCHECK PROTECTION PROGRAM
RELATED TO COVID-19
    * SALES REVENUES FOR QUARTER ENDED AT MNOK 104.5 (MNOK
82.5), AN
INCREASE OF 26.7%.
    * Q2 OPERATING PROFIT (EBIT) FOR QUARTER ENDED AT MNOK 42.7
(MNOK
27.7), A 54.0% INCREASE AND BY FAR BEST EBIT FOR A QUARTER EVER
    * HIGH GROWTH IN NUMBER OF PROCEDURES IN USA WITH 50% AS
WELL AS
CONSUMABLE PROBE SALES GROWTH WITH 35%, REFLECT AN INCREASING
NUMBER OF SURGERIES BEING PERFORMED AND CONTINUING RECOVERY FROM
COVID PANDEMIC

Source text for Eikon:  ID:nObijGFq6a 
Further company coverage:  MEDS.OL 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))